PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy

Table 1

Seventy-three patients were included in this study. Clinical and ophthalmologic characteristics were presented as mean ± standard deviation.

Group	TAO	Control
Case	45	28
Sex (M/F)	14/31	9/19
Age (y)
NOSPECS		NA
CAS		NA
TSH (mIU/L)		NA
T3 (nmol/L)		NA
T4 (nmol/L)		NA
FT3 (pmol/L)		NA
FT4 (pmol/L)		NA

M: male; F: female; NOSPECS: American Thyroid Association (ATA) classification of the orbital changes in Graves’ disease [16]. CAS: clinical activity score (seven scores in total); TSH: thyroid-stimulating hormone; T3: triiodothyronine; T4: serum thyroxine; FT3: free triiodothyronine; FT4: free thyroxine; NA: not applicable.